Tradestie Institutional Equity Comparison Engine

EVMN vs AGMB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EVMN Overall Edge

EVMN Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Evommune, Inc. (EVMN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EVMN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus AGMB at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, EVMN sits in SURGE (53rd %ile IV; Dealer Gamma Walls on Pro) against AGMB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
EVMN N/M vs AGMB N/M Fwd P/E
Growth & Margin Winner EVMN
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner EVMN
1Y -61.0% vs -59.2% ยท 52W Pos 8% vs 2%
Options & Structure Winner EVMN
SURGE (53rd %ile IV) vs UNCLASSIFIED (N/A IV)
EVMN US Equity
Evommune, Inc.
Pharmaceutical Preparations
$7.10
-6.95% 1D
Market Cap $315.5M
1M Return +37.33%
1Y Return -61.03%
Forward P/E N/M
Unified AI Score
30.0 / 100 SELL
Tech 50.0 Fund 35.0 Flow 69.0 Mom 44.0
AGMB US Equity
AGMB
Institutional Equity
$5.97
-6.13% 1D
Market Cap N/A
1M Return -27.9%
1Y Return -59.25%
Forward P/E N/M
Unified AI Score
40.9 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EVMN -61.03% AGMB -59.25% Spread: +0.27 pp (EVMN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EVMN TTM Op. Margin: 0.0% AGMB TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVMN vs AGMB. Trailing 12-month operating profitability (EVMN 0.0% vs AGMB N/A) and valuation multiples (EVMN N/M vs AGMB N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EVMN (6) vs AGMB (2)
Institutional Metric EVMN AGMB Criterion Row Winner
Market Capitalization Scale $315.5M N/A Larger Scale EVMN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% N/A Higher Growth EVMN
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin EVMN
Net Profit Margin Profitability 0.0% N/A Higher Margin EVMN
Return on Equity (ROE) Capital Efficiency -69.5% N/A Higher ROE EVMN
52-Week Range Position Momentum 8% ($5โ€“$33) 2% ($6โ€“$18) Stronger Trend EVMN
Beta / 30D Volatility Risk Regime 1.05ฮฒ ยท 118% Vol 1.44ฮฒ ยท 78% Vol Lower Realized Risk AGMB
Unified Institutional Score Composite Signal 30.0 / 100 (SELL) 40.9 / 100 (SELL) Higher Composite AGMB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EVMN vs AGMB Buy Guide
EVMN SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EVMN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AGMB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AGMB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EVMN nor AGMB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.